# Kenneth Greenberg

> Kenneth Greenberg is a Berkeley-trained researcher and repeat company founder who serves as Co-Founder, President and CEO of SonoThera. His career includes co-founding Spiral Devices, CODA Biotherapeutics and Oncorus, leading a discovery program at UNITY Biotechnology, and supporting strategic partnerships at Janssen. SonoThera announced a $125 million Series B led by Vida Ventures in June 2026.

- **Role:** Co-Founder, President & CEO at SonoThera
- **Organizations:** SonoThera, Spiral Devices, CODA Biotherapeutics, Oncorus, UNITY Biotechnology, Janssen / Johnson & Johnson, University of California, Berkeley
- **Education:** Ph.D. in Visual Neuroscience, University of California, Berkeley, Kirschstein-NRSA postdoctoral fellowship in MCB Neurobiology, University of California, Berkeley
- **Known for:** Co-founded Spiral Devices to commercialize a Berkeley invention; first products sold in 2013., Co-founded CODA Biotherapeutics, Oncorus and SonoThera., SonoThera announced a $60.75 million Series A in December 2022 and a $125 million Series B in June 2026.

## Career timeline

- **2011** — Co-founded Spiral Devices to commercialize technology invented during his Berkeley postdoctoral fellowship; the company was incubated at QB3 East Bay Innovation Center.
- **2013** — Spiral Devices sold its first products.
- **—** — Co-founded CODA Biotherapeutics and Oncorus, with responsibilities spanning financing, discovery and scientific strategy.
- **—** — Created and led a discovery program at UNITY Biotechnology.
- **—** — Led external innovation efforts at Janssen covering Western North America, Australia and New Zealand.
- **2022** — SonoThera publicly launched with Greenberg as co-founder and CEO and announced a $60.75 million Series A.
- **2026** — Led SonoThera during its oversubscribed $125 million Series B and spoke at BIO International Convention about large financing rounds.

## Achievements

- Co-founded Spiral Devices to commercialize a Berkeley invention; first products sold in 2013.
- Co-founded CODA Biotherapeutics, Oncorus and SonoThera.
- SonoThera announced a $60.75 million Series A in December 2022 and a $125 million Series B in June 2026.
- Inventor on more than two dozen patents and patent applications, according to his official biography.
- Co-authored more than 50 scientific publications, according to his official biography.

## Latest updates

- **2026-10** — SonoThera was included in Fierce Biotech’s 2026 Fierce 15.
- **2026-09** — SonoThera appointed Adam Shaywitz to its leadership team.
- **2026-06** — SonoThera announced an oversubscribed $125 million Series B led by Vida Ventures on June 10.
- **2026-06** — Greenberg participated in the BIO International Convention financing panel on June 25.

## Links

- Website: https://sonothera.com/
- LinkedIn: https://www.linkedin.com/in/kenneth-greenberg-55441215/

---

Profile page: https://yespress.io/kenneth-greenberg
Published by YesPress — https://yespress.io
Last updated: 2026-10-14